期刊文献+

盐霉素对肝癌HepG2细胞体外增殖和侵袭转移能力的影响 被引量:4

Effects of Salinomycin on Proliferative,Invasive and Metastatic Abilities of Hepatoma Cell Line HepG2 in vitro
原文传递
导出
摘要 探讨盐霉素对人肝癌细胞HepG2增殖、侵袭转移能力影响的作用机制。MTT法检测盐霉素对肝癌HepG2细胞和正常肝细胞L02增殖的影响;利用FITC标记的鬼笔环肽进行微丝免疫荧光染色,激光共聚焦技术获得盐霉素作用下F-actin细胞骨架的形态变化;Transwell小室法测定盐霉素对HepG2细胞体外迁移侵袭能力的变化。Western blot法检测盐霉素对HepG2细胞中β-连环蛋白(β-catenin)、基质金属蛋白酶-2(MMP-2)及基质金属蛋白酶-9(MMP-9)蛋白表达的影响。结果显示,盐霉素抑制HepG2细胞的增殖,并呈现出时间、剂量依赖效应;而盐霉素对正常肝细胞L02的增殖抑制作用不明显。经过盐霉素(1μmol/L和4μmol/L)处理的HepG2细胞,迁移和侵袭实验中穿膜细胞数均明显低于对照组(P<0.05),且以F-actin为基础的微丝骨架结构发生紊乱。盐霉素(4μmol/L和8μmol/L)还可明显下调MMP-2、MMP-9及β-catenin蛋白的表达水平(P<0.05)。这些结果提示,盐霉素能有效抑制人肝癌细胞HepG2的增殖、迁移和侵袭,其作用机制可能与降低MMP-2、MMP-9及β-catenin蛋白的表达有关。 To investigate effects of salinomycin on the proliferative, invasive and metastatic abilities of hepatoma cell line HepG2 in vitro and analyze the possible mechanisms, MTT was used for determining the prolif- erative abilities of HepG2 and human normal liver L02 ceils. The cytoskeleton was observed using confocal laser scanning microscopy after F-actin staining by FITC-labeled phalloidin. The invasive and migratory abilities were detected by Transwell assay. The protein expressions of 13-catenin, MMP-2 and MMP-9 at protein levels were eval- uated by Western blot. The results showed that the treatment of L02 cells with salinomycin (0-8 ~tmol/L) for 24 h and 48 h had no significant effects on cell viability. However, treatment of similar doses of salinomycin suppressedthe growth of HepG2 cells in a time and concentration dependent manner. HepG2 was treated by salinomycin (I, 4 ~tmol/L) for 24 h before invasive and migratory abilities were examined. Compared with that in the control group, the number of invasive and migratory cells was remarkably decreased (P〈0.05), the structure of F-actin micro filament cytoskeleton was significantly changed. In addition, immuno-blot showed that the expressions of 13-catenin, MMP-2 and MMP-9 at protein levels were significantly down-regulated (P〈0.05). The results suggested that the proliferative, invasive and migratory abilities of hepatoma cells could be inhibited by salinomycin, which may be related to down-regulating the protein expressions of 13-catenin, MMP-2 and MMP-9.
出处 《中国细胞生物学学报》 CAS CSCD 北大核心 2013年第5期655-660,共6页 Chinese Journal of Cell Biology
基金 兰州大学中央高校基本科研业务费专项资金(批准号:lzujbky-2010-127)资助的课题~~
关键词 盐霉素 肝癌细胞 增殖 侵袭转移 体外实验 salinomycin hepatoma cell proliferation invasion and metastasis in vitro experiment
  • 相关文献

参考文献15

  • 1Gupta PB, Onder TT, Jiang G, Tao K, Kuperwasser C, Weinberg RA, et al. Identification of selective inhibitors of cancer stern cells by high-throughput screening. Cell 2009, 138(4): 645-59.
  • 2Kim KY, Yu SN, Lee SY, Chun SS, Choi YL, Park YM, et al. Salinomycin-induced apoptosis of human prostate cancer cells due to accumulated reactive oxygen species and mitochondrial membrane depolarization. Biochem Biophys Res Commun 2011, 413(1): 80-6.
  • 3Zhang GN, Liang Y, Zhou L J, Chen SP, Chen G, Zhang TP, et al. Combination of salinomycin and gemcitabine eliminates pancreatic cancer cells. Cancer Lett 2011, 313(2): 137-44.
  • 4Kim JH, Chae M, Kim WK, Kim YJ, Kang HS, Kim HS, et al. Salinomycin sensitizes cancer cells to the effects of doxorubicin and etoposide treatment by increasing DNA damage and reducing p21 protein. Br J Pharmacol 2011, 162(3): 773-84.
  • 5Fuchs D, Daniel V, Sadeghi M, Opelz G, Naujokat C. Salinomycin overcomes ABC transporter-mediated multidrug and apoptosis resistance in human leukemia stem cell-like KG-1 a cells. Biochem Biophys Res Commun 2010, 394(4): 1098-104.
  • 6Yilmaz M, Christofori G, Lehembre F. Distinct mechanisms of tumor invasion and metastasis. Trends Mol Med 2007, 13(12): 535-41.
  • 7Costantini S, Di Bemardo G, Cammarota M, Castello G, Colonna G. Gene expression signature of human HepG2 cell line. Gene 2013, 15(2): 335-45.
  • 8Yilmaz M, Christofori G. Mechanisms of motility in metasta- sizing cells. Mol Cancer Res 2010, 8(5): 629-42.
  • 9Suzuki T, Yano H, Nakashima Y. Beta-catenin expression in hepatocellular carcinoma: A possible participation of beta-catenin in the dedifferentiation process. J Gastroenterol Hepatol 2002, 17(9): 994-1000.
  • 10Tien LT, Ito M, Nakao M, Niino D, Serik M, Nakashima M, et al. Expression of betacatenin in hepatocellular carcinoma. World J Gastroenterol 2005, 11(16): 2398-401.

同被引文献36

  • 1金世龙,刘宏鸣,刘宝华,杨俊涛,顾红光,申海军,肖静.肝癌细胞β-catenin表达及其亚细胞内分布[J].中华肝胆外科杂志,2007,13(9):632-634. 被引量:8
  • 2NUSSE R, BROWN A, PAPKOFF J, et al. A new nomenclature for int - 1 and related genes: the Wnt gene family [ J ]. Cell, 1991 , 64(2) : 231 -232.
  • 3HERMAN M A, WU M. Noncanonical Wnt signaling pathways in C. elegans converge on POP - 1/TCF and control cell polarity [J]. Front Biosei, 2004, 9: 1530-1539.
  • 4YANG Y. Wnts and wing: Wnt signaling in vertebrate limb devel- opment and museuloskeletal morphogenesis[ J]. Birth Defects Res Part C Embryo Today, 2003, 69(4) : 305 -317.
  • 5VEEMAN M T, AXELROD J D, MOON R T. Functions and mechanisms of beta - eatenin - independent Wnt signaling [ J ]. Dev Cell, 2003, 5 (3) : 367 - 377.
  • 6TYCKO B, LI C M, BUTTYAN R. The Wnt/beta - catenin path- way in Wihns tumors and prostate cancers [ J]. Curt Mol Med, 2007, 7 (5) : 479 - 489.
  • 7LEE H C, KIM M, WANDS J R. Wnt/Frizzled signaling in hepa- tocellular carcinoma[J]. Front Biosci, 2006, 11 : 1901 - 1915.
  • 8YAO H, ASHIHARA E, MAEKAWA T. Targeting the Wnt/beta- catenin signaling pathway in human cancers[J]. Expert Opin Ther Targets, 2011, 15(7) : 873 -887.
  • 9STRUTT D. Frizzled signaling and cell polatisation in Droso - phi- la and vertebrates [ J ]. Development, 2003, 130 (19) : 4501 - 4513.
  • 10WANG H Y, MALBON C C. Wnt - frizzled signaling to G - protein - coupled effeetors[ J]. Cell Mol Life Sei, 2004, 61 (1) : 69 -75.

引证文献4

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部